These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6268985)

  • 1. Modulation of platelet shape and membrane receptor binding by Ca2+-calmodulin complex.
    Kao KJ; Sommer JR; Pizzo SV
    Nature; 1981 Jul; 292(5818):82-4. PubMed ID: 6268985
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenosine diphosphate induces binding of von Willebrand factor to human platelets.
    Fujimoto T; Hawiger J
    Nature; 1982 May; 297(5862):154-6. PubMed ID: 6281653
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of the calmodulin antagonist trifluoperazine on stimulus-induced calcium mobilization, aggregation, secretion, and protein phosphorylation in platelets.
    Feinstein MB; Hadjian RA
    Mol Pharmacol; 1982 Mar; 21(2):422-31. PubMed ID: 7099144
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of phenothiazine and non-phenothiazine inhibitors of calmodulin on platelet calcium fluxes.
    White GC; Raynor ST
    Biochem Biophys Res Commun; 1982 Feb; 104(3):1066-72. PubMed ID: 7073725
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effects of calmodulin antagonists on phospholipases A2 and C in thrombin-stimulated platelets.
    Walenga RW; Opas EE; Feinstein MB
    J Biol Chem; 1981 Dec; 256(23):12523-8. PubMed ID: 6795206
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of trifluoperazine, an inhibitor of calmodulin, on platelet function.
    White GC; Raynor ST
    Thromb Res; 1980 Apr 1-15; 18(1-2):279-84. PubMed ID: 7404501
    [No Abstract]   [Full Text] [Related]  

  • 7. Identical binding site on human platelets for von Willebrand factor and bovine platelet aggregating factor.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Jan 1-15; 17(1-2):215-23. PubMed ID: 6769177
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor VIII/von Willebrand protein. Modification of its carbohydrate causes reduced binding to platelets.
    Kao KJ; Pizzo SV; McKee PA
    J Biol Chem; 1980 Nov; 255(21):10134-9. PubMed ID: 6776109
    [No Abstract]   [Full Text] [Related]  

  • 9. Involvement of calmodulin in platelet reaction.
    Kambayashi J; Morimoto K; Hakata N; Kobayashi T; Kosaki G
    Thromb Res; 1981 Jun 1-25; 22(5-6):553-8. PubMed ID: 6795749
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor VIII/von Willebrand factor: a multivalent ligand binding to platelets and collagen.
    Furlan M
    Blut; 1986 Jun; 52(6):329-36. PubMed ID: 2941086
    [No Abstract]   [Full Text] [Related]  

  • 11. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR; Williams SB; Coller BS
    J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of porcine von Willebrand factor (platelet aggregating factor) with human platelets.
    Finlay TH; Marcus DL; Kowalski S; Silber P
    Biochim Biophys Acta; 1981 Jan; 672(1):79-88. PubMed ID: 6260227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calmodulin antagonists induce platelet apoptosis.
    Wang Z; Li S; Shi Q; Yan R; Liu G; Dai K
    Thromb Res; 2010 Apr; 125(4):340-50. PubMed ID: 20172594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.
    Moore A; Ross GD; Nachman RL
    J Clin Invest; 1978 Nov; 62(5):1053-60. PubMed ID: 309473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of galactose-binding lectins on human blood platelets: identity of the peanut agglutinin receptor with the von Willebrand factor receptor.
    Naim HY; Clemetson KJ; Lüscher EF
    Thromb Res; 1982 Jun; 26(6):431-41. PubMed ID: 6287665
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of succinylation and dodecyl, succinylation on bovine factor VIII/von Willebrand factor complex.
    Thuy LP; Brown JE; Baugh RF; Hougie C
    Thromb Res; 1980 May 1-15; 18(3-4):305-13. PubMed ID: 6774433
    [No Abstract]   [Full Text] [Related]  

  • 17. Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets.
    Ruggeri ZM; Bader R; de Marco L
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6038-41. PubMed ID: 6310559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Interaction of ristocetin (R), von Willebrand factor (vWF), factor VIII clotting activity (VIIIc) and platelets.
    Zucker MB; McPherson J; Kim SJ; Macdonald VE; Taylor D; Johnson AJ; Barlow GH
    Thromb Diath Haemorrh; 1975 Nov; 34(2):582. PubMed ID: 1081748
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of calmodulin antagonist (stelazine) on agonist-induced calcium mobilization and platelet activation.
    Rao GH
    Biochem Biophys Res Commun; 1987 Oct; 148(2):768-75. PubMed ID: 3689372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The domain of platelet glycoprotein I as recognized by various antibodies, both monoclonal and polyspecific.
    Bryckaert MC; Ruan C; Tobelem G
    Blood Cells; 1983; 9(2):383-7. PubMed ID: 6229302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.